Magic mushroom compound targets Depression's Joy-Sapping symptom
NCT ID NCT07490353
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether psilocybin, the active ingredient in magic mushrooms, can help people with depression who have lost the ability to feel pleasure (anhedonia). Researchers will give 85 participants two doses of psilocybin, sometimes blocking its psychedelic effects with another drug, and use brain scans to see how it affects reward and pleasure pathways. The goal is to understand if the psychedelic experience itself is key to any mood benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Psilocybin
- What this could lead to
- If successful, this could point toward a new way to treat anhedonia (loss of pleasure) in depression, potentially improving mood and well-being.
- What could go wrong
- This is a very early Phase 1 trial with only 85 people, so results may not apply broadly. The open-label design means both participants and researchers know who gets what, which can bias results. Psilocybin can cause intense, challenging experiences.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANHEDONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Division of General Psychiatry
RECRUITINGVienna, State of Vienna, 1160, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Can a Three-Session therapy rival CBT for Event-Related depression?
- Your genes could hold the key to better depression treatment
- A therapy that aims to boost wellbeing, not just ease symptoms — a trial puts it to the test